HIMS

$25.701.82%0.46

アフターアワーズ： 25.84+0.14 +0.54%

Hims Hers Health Inc (HIMS)

Date: O: H: L: C: Vol:

前日終値:

$25.24

開ける：

$25.48

24時間の取引高:

7,339,060

相対出来高:

0.85

時価総額：

$6.00B

収益：

$2.35B

当期純損益:

$128.37M

株価収益率:

49.22

EPS:

$0.5221

ネットキャッシュフロー:

$57.42M

1W パフォーマンス:

-7.95%

1M パフォーマンス:

-11.38%

6M パフォーマンス:

-6.24%

1Y パフォーマンス:

-42.10%

1日の値動き範囲:

$25.40$26.37

1週間の範囲:

$25.15$30.13

52週間の値動き範囲:

$13.74$48.34

Hims Hers Health Inc（HIMS）会社概要

名前

Hims Hers Health Inc

セクター

Healthcare

産業

Drug Manufacturers - Specialty & Generic

電話

415-851-0195

住所

2269 CHESTNUT ST, SAN FRANCISCO, USA

職員

2,442

次回の収益日

2026-11-09

最新のSEC提出書

SEC

XでのHIMSに関するディスカッション

時価総額

収益

当期純利益

現金流量

EPS

Hims Hers Health Inc (HIMS) アップグレードとダウングレード

日付	アクション	アナリスト	評価の変更
2026-09-11	Resumed	JP Morgan	Neutral
2026-05-12	繰り返されました	Needham	Buy
2026-04-24	開始されました	JP Morgan	Overweight
2026-03-10	アップグレード	BofA Securities	Underperform → Neutral
2026-03-10	アップグレード	Citigroup	Sell → Neutral
2026-03-09	アップグレード	Needham	Hold → Buy
2026-02-24	ダウングレード	BTIG Research	Buy → Neutral
2026-01-12	開始されました	Evercore ISI	In-line
2025-12-09	開始されました	Barclays	Overweight
2025-10-21	開始されました	KeyBanc Capital Markets	Sector Weight
2025-06-23	ダウングレード	Needham	Buy → Hold
2025-06-04	繰り返されました	Needham	Buy
2025-04-29	ダウングレード	TD Cowen	Buy → Hold
2025-02-18	ダウングレード	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	ダウングレード	Citigroup	Neutral → Sell
2025-01-07	開始されました	BTIG Research	Buy
2024-12-17	開始されました	Morgan Stanley	Overweight
2024-11-14	ダウングレード	BofA Securities	Buy → Underperform
2024-08-22	開始されました	Needham	Buy
2024-08-09	ダウングレード	Imperial Capital	Outperform → In-line
2024-05-22	ダウングレード	Citigroup	Buy → Neutral
2024-04-16	ダウングレード	Jefferies	Buy → Hold
2024-04-10	開始されました	Canaccord Genuity	Buy
2024-02-28	アップグレード	Imperial Capital	In-line → Outperform
2024-02-26	開始されました	Leerink Partners	Market Perform
2023-12-07	開始されました	Imperial Capital	In-line
2023-07-28	開始されました	TD Cowen	Outperform
2023-04-11	開始されました	Robert W. Baird	Neutral
2023-02-09	アップグレード	Jefferies	Hold → Buy
2022-11-08	アップグレード	BofA Securities	Neutral → Buy
2022-11-08	アップグレード	SVB Leerink	Mkt Perform → Outperform
2022-10-17	ダウングレード	Piper Sandler	Overweight → Neutral
2022-09-07	開始されました	Truist	Hold
2022-07-15	開始されました	SVB Leerink	Underperform
2022-04-14	開始されました	Guggenheim	Buy
2022-04-01	Resumed	Credit Suisse	Outperform
2022-03-10	開始されました	Deutsche Bank	Hold
2021-12-02	開始されました	Jefferies	Hold
2021-11-11	アップグレード	Piper Sandler	Neutral → Overweight
2021-07-06	開始されました	BofA Securities	Neutral
2021-05-20	アップグレード	Credit Suisse	Neutral → Outperform
2021-04-21	開始されました	Truist	Hold
2021-03-09	開始されました	Credit Suisse	Neutral
2021-03-02	アップグレード	Citigroup	Neutral → Buy
2021-02-17	開始されました	Citigroup	Neutral
2021-02-12	開始されました	Piper Sandler	Neutral
2021-02-08	開始されました	Tigress Financial	Buy

Hims Hers Health Inc (HIMS) 財務データ

期間	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
期間終了日	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	2,347.64	1,476.51	872.00	526.92	271.88
Cost of revenue USD (M)	614.26	303.38	157.05	118.19	67.38
Gross profit USD (M)	1,733.38	1,173.14	714.95	408.72	204.49
Operating expenses USD (M)	1,627.77	1,111.23	744.40	477.42	319.54
Operating income USD (M)	105.61	61.90	-29.45	-68.70	-115.04
Income before tax USD (M)	123.92	71.71	-21.57	-65.71	-110.80
Income tax expense USD (M)	-4.44	-54.33	1.98	-0.03	-3.14
Net income USD (M)	128.37	126.04	-23.55	-65.68	-107.66
Basic EPS USD/shares	0.57	0.58	-0.11	-0.32	-0.58
Diluted EPS USD/shares	0.51	0.53	-0.11	-0.32	-0.58
Basic weighted shares shares (M)	224.96	215.94	209.34	204.52	186.78
Diluted weighted shares shares (M)	258.23	236.81	209.34	204.52	186.78
Selling, general and administrative USD (M)	-	-	-	-	183.63

Hims Hers Health Inc (HIMS) インサイダートレーディング

Boughton SoleilOct 28 '26
Officer
取引
Proposed Sale
コスト
$27.60
#株式
3,462
値 ($)
95,551
#株式総数
0
Boughton SoleilOct 28 '26
Chief Legal Officer
取引
Sale
コスト
$27.60
#株式
3,462
値 ($)
95,551
#株式総数
293,886
Boughton SoleilOct 14 '26
Officer
取引
Proposed Sale
コスト
$29.06
#株式
3,461
値 ($)
100,577
#株式総数
0
Boughton SoleilOct 14 '26
Chief Legal Officer
取引
Sale
コスト
$29.06
#株式
3,461
値 ($)
100,577
#株式総数
297,348
Okupe OluyemiOct 01 '26
Officer
取引
Proposed Sale
コスト
$29.70
#株式
2,000
値 ($)
59,400
#株式総数
0
Okupe OluyemiOct 01 '26
Chief Financial Officer
取引
Sale
コスト
$29.70
#株式
2,000
値 ($)
59,400
#株式総数
234,527
Boughton SoleilSep 30 '26
Officer
取引
Proposed Sale
コスト
$29.17
#株式
3,461
値 ($)
100,957
#株式総数
0
Boughton SoleilSep 30 '26
Chief Legal Officer
取引
Sale
コスト
$29.17
#株式
3,461
値 ($)
100,957
#株式総数
300,809
Okupe OluyemiSep 22 '26
Chief Financial Officer
取引
Sale
コスト
$29.95
#株式
29,277
値 ($)
876,846
#株式総数
236,527
Okupe OluyemiSep 22 '26
Officer
取引
Proposed Sale
コスト
$29.95
#株式
29,277
値 ($)
876,846
#株式総数
0

インサイダートレーディング	関係	日付	取引	コスト	#株式	値 ($)	#株式総数
Boughton Soleil	Officer	Oct 28 '26	Proposed Sale	$27.60	3,462	95,551	0
Boughton Soleil	Chief Legal Officer	Oct 28 '26	Sale	$27.60	3,462	95,551	293,886
Boughton Soleil	Officer	Oct 14 '26	Proposed Sale	$29.06	3,461	100,577	0
Boughton Soleil	Chief Legal Officer	Oct 14 '26	Sale	$29.06	3,461	100,577	297,348
Okupe Oluyemi	Officer	Oct 01 '26	Proposed Sale	$29.70	2,000	59,400	0
Okupe Oluyemi	Chief Financial Officer	Oct 01 '26	Sale	$29.70	2,000	59,400	234,527
Boughton Soleil	Officer	Sep 30 '26	Proposed Sale	$29.17	3,461	100,957	0
Boughton Soleil	Chief Legal Officer	Sep 30 '26	Sale	$29.17	3,461	100,957	300,809
Okupe Oluyemi	Chief Financial Officer	Sep 22 '26	Sale	$29.95	29,277	876,846	236,527
Okupe Oluyemi	Officer	Sep 22 '26	Proposed Sale	$29.95	29,277	876,846	0

Hims Hers Health Inc (HIMS) 最新ニュース

Nov 01, 2026

HIMS Deadline in 1 Day: Hims & Hers Health, Inc. (NYSE: HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP - GlobeNewswire Inc.

Nov 01, 2026

מחר המועד האחרון בעניין HIMS: רוזן, עורך דין מומחה למשקיעים, קורא למשקיעי Hims & Hers Health, Inc שספגו הפסדים העולים על 100,000 דולר, לשכור ייצוג משפטי לקראת המועד החשוב ב-2 בנובמבר במסגרת תביעה ייצוגית בענייני ניירות ערך – HIMS - GlobeNewswire Inc.

Nov 01, 2026

Oct 31, 2026

DOCS DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.

Oct 31, 2026

HIMS FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 31, 2026

Oct 29, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 29, 2026

Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know - Zacks Investment Research

Oct 29, 2026

Oct 28, 2026

HIMS 5-DAY DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action - GlobeNewswire Inc.

Oct 28, 2026

Oct 27, 2026

What Are Hims & Hers Health Stock Investors Overlooking? - Trefis

Oct 27, 2026

Oct 26, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 26, 2026

Deadline Alert: Hims & Hers Health, Inc. Investors Have - GlobeNewswire

Oct 26, 2026

HIMS 1-WEEK DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action - PR Newswire

Oct 26, 2026

Oct 25, 2026

INV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - INV - GlobeNewswire Inc.

Oct 25, 2026

FTK DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Flotek Industries, Inc. Investors to Secure Counsel Before Important October 26 Deadline in Securities Class Action - FTK - GlobeNewswire Inc.

Oct 25, 2026

HIMS FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 25, 2026

Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - GlobeNewswire Inc.

Oct 25, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRP - GlobeNewswire Inc.

Oct 25, 2026

Oct 23, 2026

Hims & Hers Health Inc (HIMS) Stock Down 4.9% -- Now Undervalued? GF Score: 75/100 - GuruFocus

Oct 23, 2026

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Yahoo Finance

Oct 23, 2026

Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Zacks Investment Research

Oct 23, 2026

Hims & Hers Defends Subscription Practices And Privacy Disclosures Against Lawsuit - Benzinga

Oct 23, 2026

Oct 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat

Oct 22, 2026

Hims & Hers Health, Inc. Tokenized Stock (Coinbase) price today, HIMSc to USD live price, marketcap and chart - CoinMarketCap

Oct 22, 2026

Hims & Hers Health (HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - The National Law Review

Oct 22, 2026

Hims Seeks Dismissal of FTC Suit Over User Data, Subscriptions - Bloomberg.com

Oct 22, 2026

Oct 21, 2026

Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo Finance

Oct 21, 2026

A New Era for Testosterone Care: Hims Launches New Injectable and Oral TRT Options - Hims & Hers Newsroom

Oct 21, 2026

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date - HIMS investor relations

Oct 21, 2026

Oct 20, 2026

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC - GlobeNewswire Inc.

Oct 20, 2026

Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd - GlobeNewswire Inc.

Oct 20, 2026

Hims & Hers Health Inc (HIMS) Shares Surge 3.8% -- What GF Score of 75 Tells Investors - GuruFocus

Oct 20, 2026

Hims & Hers Gains as It Launches Men’s Weight-Loss Care in Germany - Yahoo Finance

Oct 20, 2026

Hims & Hers Health Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet

Oct 20, 2026

What's Next for Hims & Hers Health, Inc. Shareholders After 14.73% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline - Morningstar

Oct 20, 2026

Hims & Hers gains after German launch - Seeking Alpha

Oct 20, 2026

Hims & Hers Health launches online weight management service for men in Germany - Reuters

Oct 20, 2026

Hims & Hers Health launches online weight management service for men in Germany - Yahoo Finance Singapore

Oct 20, 2026

Oct 19, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 19, 2026

Hims Is Reaching the Three Million Member Milestone - The Motley Fool

Oct 19, 2026

HIMS DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 19, 2026

What Are Hims & Hers Health Stock Bears Missing? - Trefis

Oct 19, 2026

Hims & Hers Health: The Lollapalooza Effect Of GLP-1s (NYSE:HIMS) - Seeking Alpha

Oct 19, 2026

Oct 16, 2026

Hims & Hers Health Inc (HIMS) Stock Down 4.5% -- Now Undervalued? GF Score: 75/100 - GuruFocus

Oct 16, 2026

ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRP - GlobeNewswire Inc.

Oct 16, 2026

HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 16, 2026

What Does Hims & Hers Health (HIMS) Expansion Into The UK And Australia Mean? - Yahoo Finance

Oct 16, 2026

Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - PR Newswire

Oct 16, 2026

How Is Hims & Hers Health, Inc. (NYSE:HIMS) Reshaping Its Business? - Kalkine Media

Oct 16, 2026

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research

Oct 16, 2026

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Oct 16, 2026

HIMSに類似